| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | VNLG/124 | GDSC1000 | pan-cancer | AAC | 0.27 | 6e-16 |
| mRNA | linifanib | GDSC1000 | pan-cancer | AAC | 0.27 | 3e-14 |
| mRNA | AC220 | GDSC1000 | pan-cancer | AAC | 0.27 | 6e-14 |
| mRNA | RDEA119 | GDSC1000 | pan-cancer | AAC | 0.19 | 5e-10 |
| mRNA | CI-1040 | GDSC1000 | pan-cancer | AAC | 0.19 | 1e-08 |
| mRNA | (5Z)-7-Oxozeaenol | GDSC1000 | pan-cancer | AAC | 0.17 | 3e-08 |
| mRNA | PD-0325901 | GDSC1000 | pan-cancer | AAC | 0.18 | 4e-08 |
| mRNA | dexamethasone | CTRPv2 | pan-cancer | AAC | -0.18 | 1e-07 |
| mRNA | ATRA | GDSC1000 | pan-cancer | AAC | 0.18 | 2e-07 |
| mRNA | AZD6244 | CCLE | pan-cancer | AAC | 0.21 | 9e-07 |